AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.49

-$0.46 (-5.79%)

At close: Oct 30, 2026, 4:00 PM ET

$7.49

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-5.79%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

24.8

+2.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #924/1028 (Top 90%)

Full Analysis

Key Statistics

Market Data

Market Cap $368.87M

1D Range

6.61 7.96

52W Range

6.61 17.82

Valuation (TTM)

PE -8.36

PB 1.22

EV/EBITDA -2.02

Valuation (NTM)

Forward PE N/A

Forward PEG 0.34

Price Target $35.00

Cash Flow

FCF Yield -8.1%

SBC Adj. FCF Yield -8.9%

SBC Impact -10.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -51.0% | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -12.3%

ROE -19.7%

ROIC -11.8%

Financial Health

Net Cash

€251.98M ($287.8M)

Current Ratio 12.88

Interest Coverage -257.11

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

AgomAb Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing novel, disease-modifying therapies. Its primary focus lies in immunology and inflammatory ailments, parti...

Sector Healthcare

Industry Biotechnology

Employees 62

IPO Date Feb 6, 2026

Website agomab.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.